James Brewer

7.7k total citations · 1 hit paper
39 papers, 2.7k citations indexed

About

James Brewer is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience. According to data from OpenAlex, James Brewer has authored 39 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Psychiatry and Mental health, 20 papers in Physiology and 15 papers in Cognitive Neuroscience. Recurrent topics in James Brewer's work include Dementia and Cognitive Impairment Research (33 papers), Alzheimer's disease research and treatments (20 papers) and Functional Brain Connectivity Studies (11 papers). James Brewer is often cited by papers focused on Dementia and Cognitive Impairment Research (33 papers), Alzheimer's disease research and treatments (20 papers) and Functional Brain Connectivity Studies (11 papers). James Brewer collaborates with scholars based in United States, Norway and Austria. James Brewer's co-authors include Linda K. McEvoy, Anders M. Dale, Christine Fennema‐Notestine, Donald J. Hagler, Dominic Holland, Kristine B. Walhovd, Anders M. Fjell, David S. Karow, Sebastian Magda and Michael S. Rafii and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and NeuroImage.

In The Last Decade

James Brewer

36 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

One-Year Brain Atrophy Evident in Healthy Aging

2009 501 citations Anders M. Fjell, Kristine B. Walhovd et al. Journal of Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Brewer United States	21	1.5k	1.2k	1.1k	692	437	39	2.7k
Samantha Galluzzi Italy	29	1.2k 0.8×	872 0.7×	884 0.8×	651 0.9×	512 1.2×	68	2.7k
Audrey Perrotin France	23	1.5k 1.0×	1.3k 1.1×	1.1k 1.0×	485 0.7×	319 0.7×	50	2.7k
Nicolai Franzmeier Germany	27	1.2k 0.8×	1.2k 1.0×	1.0k 1.0×	474 0.7×	695 1.6×	82	3.1k
Sarah K. Madsen United States	28	907 0.6×	1.0k 0.9×	637 0.6×	725 1.0×	296 0.7×	53	2.6k
Grégoria Kalpouzos Sweden	29	908 0.6×	1.2k 1.0×	576 0.5×	488 0.7×	302 0.7×	96	2.7k
Jimit Doshi United States	30	897 0.6×	1.2k 1.0×	537 0.5×	902 1.3×	511 1.2×	62	3.1k
Roberta Perri Italy	34	1.6k 1.1×	1.6k 1.4×	733 0.7×	445 0.6×	288 0.7×	92	2.9k
Florence Mézenge France	36	1.9k 1.2×	2.2k 1.9×	1.3k 1.3×	764 1.1×	433 1.0×	75	3.9k
Bernard Hanseeuw Belgium	33	1.7k 1.1×	1.5k 1.3×	1.5k 1.4×	376 0.5×	428 1.0×	126	3.3k
Richard J. Caselli United States	24	1.1k 0.7×	656 0.6×	1.1k 1.0×	474 0.7×	318 0.7×	57	2.7k

Countries citing papers authored by James Brewer

Since Specialization

Citations

This map shows the geographic impact of James Brewer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Brewer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Brewer more than expected).

Fields of papers citing papers by James Brewer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Brewer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Brewer. The network helps show where James Brewer may publish in the future.

Co-authorship network of co-authors of James Brewer

This figure shows the co-authorship network connecting the top 25 collaborators of James Brewer. A scholar is included among the top collaborators of James Brewer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Brewer. James Brewer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiu, Yuqi, Diane M. Jacobs, Karen Messer, et al.. (2025). Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease. Alzheimer s Research & Therapy. 17(1). 97–97.

Kutas, Marta, David P. Salmon, Sarah Farias, et al.. (2024). Memory-related brain potentials for visual objects in early AD show impairment and compensatory mechanisms. Cerebral Cortex. 34(10).

Ross, Ryan D., et al.. (2021). Sleep and Tau Pathology in Vietnam War Veterans with Preclinical and Prodromal Alzheimer’s Disease. Journal of Alzheimer s Disease Reports. 5(1). 41–48. 5 indexed citations

Peavy, Guerry M., Cecily Jenkins, Emily A. Little, et al.. (2020). Community memory screening as a strategy for recruiting older adults into Alzheimer’s disease research. Alzheimer s Research & Therapy. 12(1). 78–78. 4 indexed citations

Reas, Emilie T., et al.. (2019). Tau and atrophy: domain-specific relationships with cognition. Alzheimer s Research & Therapy. 11(1). 65–65. 43 indexed citations

Smirnov, Denis S., Douglas Galasko, Lawrence A. Hansen, et al.. (2018). Trajectories of cognitive decline differ in hippocampal sclerosis and Alzheimer's disease. Neurobiology of Aging. 75. 169–177. 15 indexed citations

Rafii, Michael S., James Brewer, Michael Donohue, et al.. (2015). The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer’s disease biomarkers in down syndrome. Frontiers in Behavioral Neuroscience. 9. 239–239. 64 indexed citations

Yu, Peng, Jia Sun, Robin Wolz, et al.. (2013). Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size. Neurobiology of Aging. 35(4). 808–818. 32 indexed citations

Desikan, Rahul S., Linda K. McEvoy, Dominic Holland, et al.. (2012). Apolipoprotein Eε4 Does Not Modulate Amyloid-β–Associated Neurodegeneration in Preclinical Alzheimer Disease. American Journal of Neuroradiology. 34(3). 505–510. 15 indexed citations

10.

McEvoy, Linda K., Dominic Holland, Donald J. Hagler, et al.. (2011). Mild Cognitive Impairment: Baseline and Longitudinal Structural MR Imaging Measures Improve Predictive Prognosis. Radiology. 259(3). 834–843. 75 indexed citations

11.

Nettiksimmons, Jasmine, Danielle Harvey, James Brewer, et al.. (2010). Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline. Neurobiology of Aging. 31(8). 1419–1428. 54 indexed citations

12.

McEvoy, Linda K. & James Brewer. (2010). Quantitative structural MRI for early detection of Alzheimer’s disease. Expert Review of Neurotherapeutics. 10(11). 1675–1688. 59 indexed citations

13.

Karow, David S., Linda K. McEvoy, Christine Fennema‐Notestine, et al.. (2010). Relative Capability of MR Imaging and FDG PET to Depict Changes Associated with Prodromal and Early Alzheimer Disease. Radiology. 256(3). 932–942. 94 indexed citations

14.

Murphy, Elizabeth, Dominic Holland, Michael Donohue, et al.. (2010). Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls. NeuroImage. 53(4). 1310–1317. 62 indexed citations

15.

McEvoy, Linda K., Steven D. Edland, Dominic Holland, et al.. (2010). Neuroimaging Enrichment Strategy for Secondary Prevention Trials in Alzheimer Disease. Alzheimer Disease & Associated Disorders. 24(3). 269–277. 37 indexed citations

16.

Seibert, Tyler M., Donald J. Hagler, & James Brewer. (2010). Early parietal response in episodic retrieval revealed with MEG. Human Brain Mapping. 32(2). 171–181. 8 indexed citations

17.

Fjell, Anders M., Kristine B. Walhovd, Christine Fennema‐Notestine, et al.. (2009). One-Year Brain Atrophy Evident in Healthy Aging. Journal of Neuroscience. 29(48). 15223–15231. 501 indexed citations breakdown →

18.

Kovačević, Sanja, Michael S. Rafii, & James Brewer. (2009). High-throughput, Fully Automated Volumetry for Prediction of MMSE and CDR Decline in Mild Cognitive Impairment. Alzheimer Disease & Associated Disorders. 23(2). 139–145. 89 indexed citations

19.

McEvoy, Linda K., Christine Fennema‐Notestine, J. Cooper Roddey, et al.. (2009). Alzheimer Disease: Quantitative Structural Neuroimaging for Detection and Prediction of Clinical and Structural Changes in Mild Cognitive Impairment. Radiology. 251(1). 195–205. 264 indexed citations

20.

Brewer, James, Sebastian Magda, Chris N. Airriess, & Michael E. Smith. (2008). Fully-Automated Quantification of Regional Brain Volumes for Improved Detection of Focal Atrophy in Alzheimer Disease. American Journal of Neuroradiology. 30(3). 578–580. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact